Meanwhile, MSB will hopefully derisk by aligning with another BP rather than relying on Teva".
Patience ..18 months ago your comment would be considered contemplation. But as at 14/12/12012 with ;
>>P2 Spinal Fusion (36 +24 patients) completed and awaiting results >> P2 Disk trials(100 patients- rapid enrolment >12 mths) completed ; >>P 2 Big D trials ongoing since 31 Jan 2012 (we have been advised that the "Mechanism of action may be unique, shutting down multiple cytokine pathways simultaneously) ; and our CEOs comment at the AGM regarding the Intravenous Franchise ..." this is an exciting area for us and Partnering opportunity" ...
...the prospect of another alliance (of the CEPH type) is no longer just hope and IMO exceedingly becoming a good chance to being ticked off in FY13.
You cant keep a good man down and this could not be more applicable to the ever so composed, unwavering and tenacious Silviu Itescu.
Please DYOR and good weekend to ALL holders.
MSB Price at posting:
$5.92 Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)